From the Guidelines
Gabapentin is indeed considered a controlled substance in Georgia, classified as a Schedule V controlled substance since 2017. This classification is due to its potential for misuse, particularly when combined with opioids, and its involvement in overdose deaths 1. The control measures were implemented to monitor and regulate prescriptions for gabapentin through Georgia's Prescription Drug Monitoring Program (PDMP).
- Key points to consider:
- Gabapentin's controlled status means that prescriptions are subject to additional regulations and monitoring.
- Healthcare providers must check the PDMP before prescribing gabapentin.
- Pharmacists must report all dispensed prescriptions to the database.
- Refills may require a new prescription rather than simple phone authorization.
- The primary concern with gabapentin is its potential to produce effects similar to opioids at high doses and enhance the effects of other substances, leading to its controlled status in Georgia 1.
- It is essential for patients prescribed gabapentin in Georgia to be aware of these regulations and the potential risks associated with its use, particularly when combined with other substances.
- The evidence from studies such as the one published in The Lancet Psychiatry in 2019 highlights the importance of careful prescribing and monitoring of gabapentin due to its potential for dependence and withdrawal symptoms, especially when used in conjunction with opioids 1.
From the FDA Drug Label
Drug Abuse and Dependence 9.1 Controlled Substance Gabapentin is not a scheduled drug. The answer is no, gabapentin is not a controlled medicine, as it is stated that Gabapentin is not a scheduled drug 2.
From the Research
Gabapentin Controlled Substance Status in Georgia
- There is no direct evidence in the provided studies that specifically addresses whether gabapentin is a controlled medicine in Georgia.
- However, studies 3 and 4 discuss the potential for gabapentin abuse and the actions taken by some US states to reclassify it as a Schedule V controlled substance or to monitor its use through prescription monitoring programs.
- According to 4, as of 2018,14 of 51 US states and jurisdictions have implemented legislative mandates requiring pharmacovigilance programs or amended rules and regulations regarding gabapentin use, but it does not specifically mention Georgia.
- Study 3 mentions that states are taking action to track gabapentin use, but it does not provide a comprehensive list of states that have reclassified gabapentin as a controlled substance.
- The provided studies do not offer conclusive evidence on the controlled substance status of gabapentin in Georgia, suggesting the need for further research or consultation of more recent or specific regulatory updates.